ENDRA Life Sciences Inc
NASDAQ:NDRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coca-Cola Bottlers Japan Holdings Inc
OTC:CCOJY
|
JP |
|
Superior Group of Companies Inc
NASDAQ:SGC
|
US |
|
J
|
Jindal Stainless Ltd
BSE:532508
|
IN |
|
Hospital Mater Dei SA
BOVESPA:MATD3
|
BR |
|
Australian Vintage Ltd
ASX:AVG
|
AU |
ENDRA Life Sciences Inc
Total Equity
ENDRA Life Sciences Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
Total Equity
$2.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
25%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$24.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$22.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$52.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Total Equity
$1.6B
|
CAGR 3-Years
38%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$17.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
ENDRA Life Sciences Inc
Glance View
ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 22 full-time employees. The company went IPO on 2017-06-28. The firm has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of various other medical conditions. Its TAEUS technology platform application focuses on quantifying fat in the liver and stage progression of non-alcoholic fatty liver disease (NAFLD), which untreated, can progress to Non-alcoholic Steatohepatitis (NASH), fibrosis, cirrhosis, and liver cancer. The firm's TAEUS platform has various clinical applications, such as tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
See Also
What is ENDRA Life Sciences Inc's Total Equity?
Total Equity
2.3m
USD
Based on the financial report for Dec 31, 2025, ENDRA Life Sciences Inc's Total Equity amounts to 2.3m USD.
What is ENDRA Life Sciences Inc's Total Equity growth rate?
Total Equity CAGR 10Y
25%
Over the last year, the Total Equity growth was -12%. The average annual Total Equity growth rates for ENDRA Life Sciences Inc have been -32% over the past three years , -21% over the past five years , and 25% over the past ten years .
